MedTrace Logo

Prostate Cancer Prospective Cohort

NCT00937586 · Status: ACTIVE_NOT_RECRUITING · Type: OBSERVATIONAL · Enrollment: 1937

Last updated 2025-12-17

No results posted yet for this study

Summary

The overall purpose of this research is to determine if certain genes increase the chance of developing prostate cancer and once diagnosed increase the chance of the prostate cancer spreading to other parts of the body.

Conditions

Sponsors & Collaborators

  • Johns Hopkins University

    collaborator OTHER

  • National Cancer Institute (NCI)

    collaborator NIH

  • Wake Forest University

    collaborator OTHER

  • Washington University School of Medicine

    lead OTHER

Principal Investigators

  • Bettina Drake, PhD · Washington University School of Medicine

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-05-31
Primary Completion
2027-06-30
Completion
2027-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00937586 on ClinicalTrials.gov